Skip to Content

Dyphylline / guaifenesin Pregnancy and Breastfeeding Warnings

Dyphylline / guaifenesin is also known as: COPD, D-G, Difil G, Difil-G Forte, Dilex-G, Dilex-G 200, Dilex-G 400, Dilor-G, Dy-G, Dyfilin GG, Dyflex-G, Dyline GG, Dyphyl GG, Dyphyllin-GG, Dyphylline GG, Dyphylline GG ES, Jay-Phyl, LGG, Lufyllin-GG, Panfil G

Medically reviewed on January 9, 2018

Dyphylline / guaifenesin Pregnancy Warnings

Dyphylline-guaifenesin has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Guaifenesin is only recommend for use during pregnancy when benefit outweighs risk.

See references

Dyphylline / guaifenesin Breastfeeding Warnings

Dyphylline is present in human milk at approximately twice the maternal plasma concentration. There are no data on the excretion of guaifenesin into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Panfil G (dyphylline-guaifenesin)." Pamlab LLC, Mandeville, LA.

References for breastfeeding information

  1. "Product Information. Panfil G (dyphylline-guaifenesin)." Pamlab LLC, Mandeville, LA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.